In more advanced cases, the condition can lead to infection, intestinal rupture, sepsis, and even death
the invention provides methods of preventing weakness in a patient with Parkinson's disease and/or of improving or restoring muscle strength of a patient with Parkinson's disease
Reported side effects Mild headache or fatigue typically transient during initial use Mild gastrointestinal discomfort reported in some oral formulation users Sleep disruption or irritability potential sign of overstimulation Theoretical safety concerns Critical note: Because Dihexa activates the HGF/c-Met pathway which promotes cellular growth and repair there is a theoretical concern that it could potentially stimulate unwanted cell proliferation in individuals with active cancer or high cancer risk
A study on the effect of natural products against the transmission of B.1.1.529 Omicron
BCBS Ozempic Coverage Updates Its worth noting that some BCBS plans have recently tightened, or even stopped, coverage for GLP-1 drugs for individuals without type 2 diabetes, although they continue to cover them for patients with a diagnosis of type 2 diabetes
